Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
16 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Brexpiprazole“
Suchtreffer
Begriffe & Kennungen
Rxulti · 4.5 · Based on results of in vitro studies, brexpiprazole is unlikely to cause clinically important pharmacokinetic
Eintrag öffnenRxulti · 4.5 · Brexpiprazole is predominantly metabolised by CYP3A4 and CYP2D6.
Eintrag öffnenRxulti · 4.5 · CYP2D6 inhibitors Co-administration of a 2 mg single oral dose of brexpiprazole with quinidine (324 mg/day for
Eintrag öffnenRxulti · 4.5 · If brexpiprazole is administered concomitantly with medicinal products known to cause QT prolongation (e.g. mo
Eintrag öffnenRxulti · 4.5 · If brexpiprazole is administered concomitantly with medicinal products known to increase creatine phosphokinas
Eintrag öffnenRxulti · 4.5 · Pharmacodynamic interactions No information on pharmacodynamic interactions of brexpiprazole is available at p
Eintrag öffnenRxulti · 4.5 · Potential for brexpiprazole to affect other medicinal products
Eintrag öffnenRxulti · 4.5 · Potential for other medicinal products to affect brexpiprazole
Eintrag öffnenRxulti · 4.8 · Akathisia The incidence of akathisia in the brexpiprazole-treated paediatric subjects in a short-term, randomi
Eintrag öffnenRxulti · 4.8 · Nausea For nausea, the incidence in the 2 mg to 4 mg brexpiprazole group was 2.3 % overall in short-term contr
Eintrag öffnenRxulti · 4.8 · Prolactin The incidence of blood prolactin increased was 0.9 % in the 2 mg to 4 mg brexpiprazole group compare
Eintrag öffnenRxulti · 4.8 · QT prolongation In the short-term controlled trials with brexpiprazole, 3 TEAEs related to QT prolongation wer
Eintrag öffnenRxulti · 4.8 · The effects of brexpiprazole at therapeutic (4 mg) and supra-therapeutic (12 mg) doses on QT interval were eva
Eintrag öffnenRxulti · 4.8 · The incidences of the ADRs associated with brexpiprazole therapy are tabulated below. The table is based on ad
Eintrag öffnenbrexpiprazole
Eintrag öffnenbrexpiprazole
Eintrag öffnen